Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer - Wikidata - wikimedia - TriplyDB

Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer

Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer

http://www.wikidata.org/entity/Q28291526

about

Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis A sting in the tail: the N-terminal domain of the androgen receptor as a drug target Targeting the adaptive molecular landscape of castration-resistant prostate cancer AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer Proline, glutamic acid and leucine-rich protein-1 is essential for optimal p53-mediated DNA damage response PELP1 suppression inhibits colorectal cancer through c-Src downregulation PELP1: a review of PELP1 interactions, signaling, and biology Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs In vivo modulation of hypoxia-inducible signaling by topographical helix mimetics.Glucagon-like peptide-1 (GLP-1) analogs: recent advances, new possibilities, and therapeutic implications.Probing Protein Surfaces: QSAR Analysis with Helix Mimetics.Synthesis of highly functionalized oligobenzamide proteomimetic foldamers by late stage introduction of sensitive groups.Androgen Receptor Coregulator CTBP1-AS Is Associated With Polycystic Ovary Syndrome in Chinese Women: A Preliminary Study.KDM4/JMJD2 Histone Demethylase Inhibitors Block Prostate Tumor Growth by Suppressing the Expression of AR and BMYB-Regulated Genes.Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening.Regulators of Androgen Action Resource: a one-stop shop for the comprehensive study of androgen receptor action.miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47 Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer Mouse Spermatogenesis Requires Classical and Nonclassical Testosterone Signaling.PELP1: Structure, biological function and clinical significance.Protein domain mimetics as in vivo modulators of hypoxia-inducible factor signaling.Evaluating minimalist mimics by exploring key orientations on secondary structures (EKOS)Hollow boron nitride nanospheres as boron reservoir for prostate cancer treatment.Molecular pathways: targeting resistance in the androgen receptor for therapeutic benefit ELF5-Mediated AR Activation Regulates Prostate Cancer Progression.Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects PI-3 kinase p110β: a therapeutic target in advanced prostate cancers.Progress in antiandrogen design targeting hormone binding pocket to circumvent mutation based resistance Metastatic castration-resistant prostate cancer: targeting the mechanisms of resistance to abiraterone acetate and enzalutamide.Drug discovery in advanced prostate cancer: translating biology into therapy.Androgen Signaling in Prostate Cancer.Rationale for the development of alternative forms of androgen deprivation therapy.Side-Chain Conformational Preferences Govern Protein-Protein Interactions.Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer.Synthesis of a tetrasubstituted tetrahydronaphthalene scaffold for α-helix mimicry via a MgBr2-catalyzed Friedel-Crafts epoxide cycloalkylation.ChIP-seq analysis of androgen receptor in LNCaP cell line.Developing new targeting strategy for androgen receptor variants in castration resistant prostate cancer.Carbonylation as a novel method for the assembly of pyrazine based oligoamide alpha-helix mimetics.

P2860

Q21999477-5D50DA12-8D25-4882-84EE-AB1C26F48D9E Q24301596-71C170A0-2BD1-41E8-82F2-5538E7579C97 Q26747094-8A1EDAFE-78EB-404B-AA83-69ABDDBB8794 Q27022821-6CDDD0DB-7B40-49BF-9A54-D1C22B717608 Q27853062-24E7C5A4-20FB-478F-B722-C42040F9E5DF Q28239216-EDC369B9-3D53-4E20-9577-D08DF5EBF4F5 Q28242802-F6BAA008-BA40-4929-A676-05CA423A5273 Q28296277-458F6189-8368-49D1-9914-970E81E04DF0 Q33568421-2E4B593F-3E5B-4C98-A336-E66AC7EE9D2F Q33694597-5E952BF7-1BD9-4C4C-B48D-6184503A062B Q35087846-B5B5A4D1-2247-4453-86B9-95C62AE7D32A Q35874377-028B2F73-7C62-4357-91C1-3FB71D022E7F Q35966915-7BF65CF0-F424-4F09-9020-CC9B3C4FA5B5 Q36047192-830FBF78-FBB6-43C5-84FD-500303885AD0 Q36081856-573D0967-D94E-43B7-B294-CE5EBD1BEFD1 Q36386200-6CD9698B-6B46-460D-9671-F601424206A4 Q36578330-BFCC53F9-F518-41C7-9C54-3B58897ACF0C Q36685489-641B6BBF-79BB-4C25-864A-320040DA61D3 Q36693131-9F80FA8F-A61A-4D56-B001-8FCF7B1BAF9C Q36734054-A83C634F-3A7D-4C91-9682-1BE3685C8056 Q36818434-DA875FF0-C12B-4780-8E7F-66887284FEA3 Q37203888-86BDD1DA-FD07-477B-B6DC-BF450A346C8A Q37389980-311B0704-D660-44A4-BC47-E9D745ECC32D Q37582113-4C4B40B8-FE8C-487B-89AE-F766B12170F4 Q37620953-25E3E86D-D109-454F-B08A-1AFC2E5BA27F Q37695373-DE9C8AE9-0385-4D0C-A236-47002CACAF7F Q38212470-42CE4E7E-9F01-454B-9D6E-96658A8A50D6 Q38265574-24CB72B1-0338-42FA-A372-EFF9150309CD Q38410885-5386B5F8-7088-45D7-9006-0147C2B900F9 Q38541877-405FBA7D-6010-4B7C-ACD9-2AA6A90B1931 Q38839110-5D6A70C6-F4ED-4234-808D-B6CB2C7C7B09 Q39227656-5A7DEF4E-297C-4814-A7C3-C5DFB9750D9B Q39342369-D6BFDDC5-8D85-485F-81FA-34AB34278707 Q40977293-4C2968EC-89FB-4C4A-9618-D90CC314378B Q41305086-5AD0D51C-FB98-4965-9D79-E47B82845041 Q41691950-88698139-9C9E-4F16-961D-15E89FD13CE8 Q42062610-0FB0ABD0-6B2D-4215-8D1C-D6C46BF113D1 Q45915898-4A86A1F8-A546-4CC9-8029-85C6FFEF6100 Q48103666-4CF46158-E133-4BF5-8122-F901C8761DD3 Q48183478-5B2AA2CE-B627-4998-B381-4677F6E2324B

P2860

Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer

http://www.wikidata.org/entity/Q28291526

description

2013 nî lūn-bûn

@nan

2013 թուականին հրատարակուած գիտական յօդուած

@hyw

2013 թվականին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Peptidomimetic targeting of cr ...... nteractions in prostate cancer

@ast

Peptidomimetic targeting of cr ...... nteractions in prostate cancer

@en

Peptidomimetic targeting of cr ...... nteractions in prostate cancer

@nl

type

label

Peptidomimetic targeting of cr ...... nteractions in prostate cancer

@ast

Peptidomimetic targeting of cr ...... nteractions in prostate cancer

@en

Peptidomimetic targeting of cr ...... nteractions in prostate cancer

@nl

prefLabel

Peptidomimetic targeting of cr ...... nteractions in prostate cancer

@ast

Peptidomimetic targeting of cr ...... nteractions in prostate cancer

@en

Peptidomimetic targeting of cr ...... nteractions in prostate cancer

@nl

P1433

Q28291526-DF715FD5-F890-4389-84F2-FB7FE00F8CC9

P1476

Q28291526-ECD87352-5960-407F-BADB-D9CA17A13415

P2093

Q28291526-204EC924-6BA7-48E6-9160-0927D6431882

Q28291526-2EBF0971-7A2D-4237-A987-925C4DF0F34A

Q28291526-2FF01AE2-D4F3-4329-A032-616794E71400

Q28291526-86F930AE-BB08-4A67-82A6-85C028FB04C0

Q28291526-F107E1CD-B28B-4B21-8B29-6CE967ED4FAE

Q28291526-F96EE67A-D9FD-484C-ADF7-0B49AD05BA3C

P2860

Q28291526-0170EA91-B0A5-4CE0-BADD-D87B47916D07

Q28291526-0644EAEF-331E-43EB-8FB0-B398D7E0DB23

Q28291526-07C03E79-547E-4631-8D1A-8019CA3A351A

Q28291526-0968854B-B527-4D72-9BCD-F2B7C196849A

Q28291526-125125C2-4894-4C5D-9DB1-E1375A4CFA59

Q28291526-1825F997-EA7F-48B0-B296-D7AA16EE0896

Q28291526-20909042-6BE6-4FE4-8CA0-56848A1E22B7

Q28291526-2D67C4BF-F60F-49D8-A67D-BAD190277823

Q28291526-3C8768C2-18F9-404A-B9F4-2B8A39C8A4D8

Q28291526-3F167DC9-E8C8-4D56-8C02-A2FCF6CD55FA

P2888

Q28291526-329A49AE-7B44-4A1B-B3D0-997EC936A849

P304

Q28291526-C81EE856-F7E3-4C12-89CC-A481CEE12F2C

P31

Q28291526-0411FE9C-D803-45C4-BA54-84B44CE6B277

P3181

Q28291526-905FFC74-A393-46A9-B398-A2D4AA78102F

P356

Q28291526-A698D6CA-4E4C-4BCA-A4AE-D2FDBD085B0B

P407

Q28291526-A65D1914-5573-4339-B896-D61DCDDCF144

P478

Q28291526-F88F54D6-153C-4D4C-AD71-1F022F850605

P50

Q28291526-38259BD2-0F6D-4B5B-B7D4-9863742A3066

Q28291526-9F1E4A4F-7739-45BB-BB23-DA7D6996EDC3

Q28291526-B0B2FF3D-6A55-4A76-9478-394E8FDEF78B

P577

Q28291526-123ECE55-41FC-402A-84D2-6609E1965CFC

P6179

Q28291526-7CCD5CCC-7182-45B0-A9CB-51F119CF5474

P698

Q28291526-9E41D398-ECBF-407D-AA0D-F8D575B091B4

P3181

P356

P1433

Nature Communications

P1476

Peptidomimetic targeting of cr ...... nteractions in prostate cancer

@en

P2093

Ganesh V Raj

http://www.w3.org/2001/XMLSchema#string

Jer-Tsong Hsieh

http://www.w3.org/2001/XMLSchema#string

Lin Yang

http://www.w3.org/2001/XMLSchema#string

Preethi Ravindranathan

http://www.w3.org/2001/XMLSchema#string

Tae-Kyung Lee

http://www.w3.org/2001/XMLSchema#string

Wayne D Tilley

http://www.w3.org/2001/XMLSchema#string

P2860

The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study

Development of a second-generation antiandrogen for treatment of advanced prostate cancer

Recognition and accommodation at the androgen receptor coactivator binding interface

Molecular determinants of resistance to antiandrogen therapy

Significance of PELP1 in ER-negative breast cancer metastasis

Central role for PELP1 in nonandrogenic activation of the androgen receptor in prostate cancer

PELP1: A novel therapeutic target for hormonal cancers

Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

P2888

P304

1923

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1531162

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NCOMMS2912

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Margaret M Centenera

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1047915883

http://www.w3.org/2001/XMLSchema#string

P698

23715282

http://www.w3.org/2001/XMLSchema#string